A new genetic test that analyzes the free DNA floating in a pregnant woman's blood was proven to be more effective at predicting chromosomal disorders compared with standard screening tests, due to its much smaller incidence of false-positive results. This is significant for women who may no longer have to undergo invasive testing just to confirm the positive results of standard tests.
